-
More than 80 medicines banned from parallel export out
of UK
-
Measures to protect supplies of crucial treatments used
in intensive care units
-
Adrenaline, insulin, paracetamol and morphine included
on ban list
More than 80 crucial medicines commonly used to treat patients in
NHS intensive care units have been banned from parallel export
out of the UK.
The new restrictions, which cover medicines including adrenaline,
insulin, paracetamol and morphine, have been imposed by the
Government and will help ensure there is an uninterrupted supply
of medicines for NHS hospitals treating coronavirus patients.
Parallel exporting is when companies buy medicines meant for UK
patients and sell on for a higher price in another country,
potentially causing or aggravating supply problems.
All medicines on the list are in high demand across Europe as
health systems come under increasing pressure from coronavirus.
Today’s action is a standard measure to manage potential medicine
shortages and protects UK patients by ensuring the NHS has the
vital treatments to continue providing world-class care.
Health Minister
said:
“Our brilliant NHS staff are going above and beyond to provide
world-class care to patients with coronavirus and we are
supporting them in every way we can.
“We are today banning the parallel export of more than 80 crucial
medicines to protect patients in the UK and help ensure they can
always get the treatments they need.”
Companies that parallel export a medicine on the ban list may
face tough enforcement action from the Medicines and Healthcare
products Regulatory Agency (MHRA) and risk having their trading
licence revoked for serious breaches.
The Government will keep the situation under review and will
consider adding more medicines to the parallel export ban list if
necessary.
The Department of Health and Social Care has existing,
well-established processes to deal with and resolve medicines
shortages. The medicine supply chain is complex and highly
regulated, so problems can arise for a variety of reasons,
including manufacturing issues or problems with raw ingredients.
Notes to Editors
The list of medicines banned from parallel export are:
Accusol 35
Adrenaline
Albumin
Alfentanil
Amikacin
Amiodarone
Amoxicillin
Anidulafungin
Argipressin
Atracurium
Calcium
Caspofungin
Ceftazidime
Ceftriaxone
Cefuroxime
Cisatracurium
Clarithromycin
Clonidine
Co-amoxiclav
Cyclizine
Dalteparin
Dexmedetomidine
Dobutamine
Enoxaparin
Epoprostenol
Erythromycin
Esmolol
Esomeprazole
Fentanyl
Flucloxacillin
Furosemide
Gentamicin
Glyceryl trinitrate
Granisetron
Hemolactol
Hemosol B0
Heparin sodium
Hydrocortisone
Insulin
Ketamine
Lactasol
Lansoprazole
Levofloxacin
Linezolid
Lorazepam
Magnesium
Meropenem
Metaraminol
Metoclopramide
Micafungin
Midazolam
Milrinone
Monosul
Morphine
Morphine sulfate
Noradrenaline
Omeprazole
Ondansetron
Oxycodone
Pantoprazole
Paracetamol
Piperacillin
Plasma-Lyte
Potassium chloride
Potassium chloride
Prednisolone
Prismasol 4
PrismOcal B22
Prismocitrate 18/0
Propofol
Remifentanil
Rifampicin
Rocuronium
Sodium chloride
Sodium dihydrogen phosphate
Sodium lactate
Suxamethonium
Teicoplanin
Terlipressin
Tinzaparin
Vancomycin
Voriconazole
